Buying beaten down biotech stocks is a strategy I focus on, especially at the end of each year because as tax loss selling fades, it is possible to see very strong gains into the New Year. For example, last December, I wrote an article about Immunogen (IMGN) titled “Why This $1 Biotech Stock Is A Strong Buy Now” and that stock went to over $8.50 per share in 2017. Almost a year ago,....More>>>
Investment company Independent Advisor Alliance buys Vanguard Total Stock Market, iShares Core U.S. Aggregate Bond, PowerShares QQQ Trust Series 1, PowerShares Preferred Portfolio, Vanguard Total Bond Market, SPDR Dow Jones Industrial Average, SPDR Bloomberg Barclays Intl Treasury Bd, SPDR MidCap Trust Series I, iShares S&P 500 Growth, iShares Core S&P 500, sells Alphabet Inc, Spectra Energy....More>>>
SpaceX just kicked off this weekend’s rocket launch double feature.
The private space company — headed by Tesla (TSLA) CEO Elon Musk — blasted a communications satellite into orbit from Kennedy Space Center in Cape Canaveral, Florida.
SpaceX is slated to make another launch on Sunday.
Friday’s mission marked the second time SpaceX has put a used,....More>>>
Sometimes a company pieces together a body of strategic and developmental work, explains its story — and progress — to the market, and investors slowly fall in love with the idea and gradually turn the heat up on the stock.
This is not one of those times. Although Cell MedX Corp (OTCMKTS:CMXC) has a great backstory, the chart came alive yesterday like someone flipped a switch.....More>>>
After reporting much better than expected results for its third quarter fiscal 2017 ended October 30,NVIDIA (NSDQ:NVDA)has continued to build new markets signing new collaborations with the tech giantsMicrosoft (NSDQ:MSFT)and International Business Machines (NYSE:IBM). In my view, these new developments will enable NVIDIA to maintain its impressive growth and to drive its shares even higher.
Much like the Canadian banking sector, Canadian telecoms operate in an oligopoly dominated by a few key players. These companies are Telus (NYSE:TU), Rogers (NYSE:RCI), and Bell (NYSE:BCE).
Telus is my personal favorite among these stocks, and as such I’ve decided to share my investment thesis.
Note: All prices and other information is in Canadian dollars unless otherwise specified.
Related BLK BlackRock Adds To Smart Beta Lineup With 9 Sector ETFs BlackRock: Smart Beta ETF Boom Will Continue Facebook: Overvalued And Over-Owned (Seeking Alpha)
Dividend growth, as it should be, is a point of emphasis....More>>>
The copper (NYSEARCA:JJC) rally at the end of October / beginning of November was violent; 30% in 13 sessions on the back of the election and an epic short squeeze. Unfortunately this kind of move isn’t usually sustainable and a pullback / consolidation after such a move is normal.
This was also the case for Freeport-McMoRan (NYSE:FCX). I warned on November 28th not to chase the rally.....More>>>
Inspired by reports that OPEC had come to an agreement to curb its oil output as a means of propping up floundering crude prices, stocks got Wednesday started on a rather bullish foot. They just didn’t end it that way. By the time the closing bell rang, the S&P 500 was back in the red by 0.27%, closing at 2,198.81.
It was even worse for shareholders of Valeant Pharmaceuticals Intl....More>>>
Its a snoozefest.
The S&P 500 is stuck in its narrowest range in nearly half a century and trading volume is plumbing multi-month lows. But by September, investors may be pining for the dog days of summer, with data suggesting that it is historically the worst month for stocks.
Since 1928, the S&P 500 has dropped in September 56% of the time, according to Bank of America Merrill....More>>>